Evidence map›Paper›PMID 20560212›Full record

ArticleAmerican journal of human genetics2010

Evolutionary and functional analysis of celiac risk loci reveals SH2B3 as a protective factor against bacterial infection.

Alexandra Zhernakova, Clara C Elbers, Bart Ferwerda, Jihane Romanos, Gosia Trynka, Patrick C Dubois, Carolien G F de Kovel, Lude Franke, Marije Oosting, Donatella Barisani and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 96 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
96citing papers in PubMed, 4 pooled it
11.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

96 citing papers in PubMed, 4 syntheses or guidelines pooled it, 196 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Celiac Disease and the Risk of Cardiovascular Diseases.International journal of molecular sciences · 2023
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

36 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 9 institutions in 5 countries.

Alexandra ZhernakovaComplex Genetics Section, Department of Medical Genetics, University Medical Centre Utrecht, P.O. Box 85060, 3508 AB Utrecht, The Netherlands.
Clara C Elbers
Bart Ferwerda
Jihane Romanos
Gosia Trynka
Patrick C Dubois
Carolien G F de Kovel
Lude Franke
Marije Oosting
Donatella Barisani
Maria Teresa Bardella
Finnish Celiac Disease Study Group
Leo A B Joosten
Paivi Saavalainen
David A van Heel
Carlo Catassi
Mihai G Netea
Cisca Wijmenga
Radboud University Nijmegen · NLUniversity Medical Center Groningen · NLQueen Mary University of London · GBUniversity Medical Center Utrecht · NLLeiden University Medical Center · NLMarche Polytechnic University · ITUniversity of Helsinki · FIUniversity of Milan · ITUniversity of Milano-Bicocca · IT

Funding

Type 1 Diabetes Genetics ConsortiumU01DK062418 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI RICH, STEPHEN S. · 2002 to 2007
$59.8M
Medical Research Council G0000934Medical Research Council G0700545NIDDK NIH HHS U01 DK062418Wellcome Trust 068545/Z/02Wellcome Trust 084743Wellcome Trust 085475Wellcome Trust WT084743MA
6 · The paper itself

Abstract

Celiac disease (CD) is an intolerance to dietary proteins of wheat, barley, and rye. CD may have substantial morbidity, yet it is quite common with a prevalence of 1%-2% in Western populations. It is not clear why the CD phenotype is so prevalent despite its negative effects on human health, especially because appropriate treatment in the form of a gluten-free diet has only been available since the 1950s, when dietary gluten was discovered to be the triggering factor. The high prevalence of CD might suggest that genes underlying this disease may have been favored by the process of natural selection. We assessed signatures of selection for ten confirmed CD-associated loci in several genome-wide data sets, comprising 8154 controls from four European populations and 195 individuals from a North African population, by studying haplotype lengths via the integrated haplotype score (iHS) method. Consistent signs of positive selection for CD-associated derived alleles were observed in three loci: IL12A, IL18RAP, and SH2B3. For the SH2B3 risk allele, we also show a difference in allele frequency distribution (Fst) between HapMap phase II populations. Functional investigation of the effect of the SH2B3 genotype in response to lipopolysaccharide and muramyl dipeptide revealed that carriers of the SH2B3 rs3184504*A risk allele showed stronger activation of the NOD2 recognition pathway. This suggests that SH2B3 plays a role in protection against bacteria infection, and it provides a possible explanation for the selective sweep on SH2B3, which occurred sometime between 1200 and 1700 years ago.

Indexed as

Disease SusceptibilityPolymorphism, Single NucleotideSelection, GeneticAdaptor Proteins, Signal TransducingAfrica, NorthernBacterial InfectionsCeliac DiseaseEuropeEvolution, MolecularGenetics, PopulationHumansIntracellular Signaling Peptides and ProteinsNod2 Signaling Adaptor ProteinProteinsAdaptor Proteins, Signal TransducingIntracellular Signaling Peptides and ProteinsNOD2 protein, humanNod2 Signaling Adaptor ProteinProteinsSH2B3 protein, human

Identifiers

PMID20560212
PMCPMC3032060
OpenAlexW2150291527

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.